GtoPdb is requesting financial support from commercial users. Please see our sustainability page for more information.

polatuzumab vedotin   Click here for help

GtoPdb Ligand ID: 8404

Synonyms: ACD79B-VCMMAE | polatuzumab vedotin-piiq | Polivy® | RG-7596 | RG7596 | RO5541077-000
Approved drug Immunopharmacology Ligand
polatuzumab vedotin is an approved drug (FDA (2019), EMA (2020))
Compound class: Antibody
Comment: Polatuzumab vedotin is an antibody drug conjugate containing an anti-CD79b monoclonal antibody linked to the toxin monomethyl auristatin E (MMAE, aka vedotin; PubChem CID 11542188).
Peptide sequence information for this antibody is available from its IMGT/mAb-DB record. Peptide sequence matches identify US8088378 as the claiming patent [1].
Classification Click here for help
Compound class Antibody
Approved drug? Yes. EU EMA (2020)  |  US FDA (2019)
International Nonproprietary Names Click here for help
INN number INN
9714 polatuzumab vedotin
Synonyms Click here for help
ACD79B-VCMMAE | polatuzumab vedotin-piiq | Polivy® | RG-7596 | RG7596 | RO5541077-000
Database Links Click here for help
GtoPdb PubChem SID 252166614
Search PubMed clinical trials polatuzumab vedotin
Search PubMed titles polatuzumab vedotin
Search PubMed titles/abstracts polatuzumab vedotin
Wikipedia Polatuzumab_vedotin